touchIME

How can we better support patients with EGFR-mutant early-stage NSCLC to complete their planned course of treatment? In the latest touchEXPERT FOCUS, Dr. James Yang shares expert perspectives on EGFR-directed strategies in early-stage NSCLC, exploring: 🔬 Evolving perioperative and adjuvant treatment landscape and the role of timely biomarker testing ⏱️ Evidence around optimal treatment duration and the implications of premature discontinuation 🩺 Practical approaches to adverse event management 🤝 Role of shared decision-making in supporting patients throughout treatment Watch the expert-led videos, explore the evidence and earn CME credit. ▶️ Watch now This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. #NSCLC #LungCancer #EGFR #BiomarkerTesting #MedicalEducation #CME #Oncology #HCPEducation

📊 Turn Your 2027 Education Budget Into Measurable Impact Setting your 2027 budget? Start with the evidence. 🔎 🌍 So far this year, touchIME has delivered both national and global independent medical education across 34 disease states, to HCPs in over 150 countries - primarily in the USA and Europe. On average, after taking part in our education: ✔ Knowledge and competence increased by over 25%, to 81% ✔ 76% of learners reported increased confidence ✔ More than 60% committed to changing clinical practice 📈 However, we don’t stop there. Our Learner-to-Patient Impact (LPI) framework combines qualitative and quantitative data with AI-supported behavioral analysis and sentiment mapping to reveal how education shapes HCP clinical intent and decision-making. 💬 "Your outcomes are more advanced than anything I've seen elsewhere. I'm very impressed…you take things to the next level!" - Senior Manager, Global Medical Education 📅 If your 2027 plans prioritize education designed to maximize improvements in patient care, with advanced analysis of its impact, get inTOUCH: https://lnkd.in/ecktYVsw #MedEd #CME #IME #PatientOutcomes #OutcomesDriven #MedicalAffairs #LearnerToPatientImpact #touchIME

🎓 Education that HCPs seek out ⏱️ Busy HCPs choose education that fits around their day. 💬 "touchIME produces consistently high-quality content. As a physician, I'm really grateful for all this group of professionals does to educate my colleagues and me. Quality education like this really makes a difference and benefits our patient care." - Dr John Hovanesian, UCLA and Jules Stein Eye Institute, CA, USA ⭐ "Fantastic activity; the best one we've supported." - Global Lead for External Engagement, Top 10 Pharma 💡 touchIME creates independent, expert-led education that learners can access on demand, on the channel that suits them: ✔ Webinars, podcasts, videos, interactive activities and enduring resources ✔ Chapterization facilitating androgynous learning with easy-to-return-to key content ✔ Freely accessible anytime, anywhere, on any device ✔ Driven by expert faculty, designed by pioneers in education design ✔ Measurable engagement and behavior change analysis 🔍 Finding the right activity should be simple We are continually improving how HCPs discover our education, so each learner can find the content most relevant to their specialty and interests. That means less time searching and more time learning. 🛡️ Independence is central to the trust learners place in us Supporters provide unrestricted educational grants and have no input into content. Every activity is directly shaped by experts, based on clinical need. 🤝 Interested in supporting independent education that HCPs seek out? Contact us: https://lnkd.in/e6gnF8hZ #MedicalEducation #IndependentMedicalEducation #CME #MedEd

🎓 Education that HCPs seek out ⏱️ Busy HCPs choose education that fits around their day. 💬 "touchIME produces consistently high-quality content. As a physician, I'm really grateful for all this group of professionals does to educate my colleagues and me. Quality education like this really makes a difference and benefits our patient care." - Dr John Hovanesian, UCLA and Jules Stein Eye Institute, CA, USA ⭐ "Fantastic activity; the best one we've supported." - Global Lead for External Engagement, Top 10 Pharma 💡 touchIME creates independent, expert-led education that learners can access on demand, on the channel that suits them: ✔ Webinars, podcasts, videos, interactive activities and enduring resources ✔ Chapterization facilitating androgynous learning with easy-to-return-to key content ✔ Freely accessible anytime, anywhere, on any device ✔ Driven by expert faculty, designed by pioneers in education design ✔ Measurable engagement and behavior change analysis 🔍 Finding the right activity should be simple We are continually improving how HCPs discover our education, so each learner can find the content most relevant to their specialty and interests. That means less time searching and more time learning. 🛡️ Independence is central to the trust learners place in us Supporters provide unrestricted educational grants and have no input into content. Every activity is directly shaped by experts, based on clinical need. 🤝 Interested in supporting independent education that HCPs seek out? Contact us: https://lnkd.in/ecktYVsw #MedicalEducation #IndependentMedicalEducation #CME #MedEd #HCPEducation #ClinicalEducation #MedicalAffairs #PatientOutcomes #DigitalHealth #touchIME

🧠 For adults with NF1-PNs, when should you consider medical management, surgery; or a combination of both? Effective management of neurofibromatosis type 1–associated plexiform neurofibromas (NF1-PNs) requires an individualized, multidisciplinary approach that considers not only tumor response, but also pain, function and quality of life. 🎓 In this CME-accredited touchIN CONVERSATION, neurosurgeon Prof. Allan Belzberg and medical oncologist Dr. Angela Hirbe respond to audience questions and share practical, evidence-based perspectives on state-of-the-art care. Key topics include: 🔹 Treatment decision-making and the role of targeted therapies for symptomatic NF1-PNs 🔹 Monitoring treatment response and managing MEK inhibitor–related adverse effects 🔹 Incorporating pain, functional outcomes and health-related quality of life into shared decision-making 🔹 Integrating medical and surgical approaches within multidisciplinary care 💬 “There are clearly times when a plexiform neurofibroma should be managed surgically, and there are times when it can be managed medically, and times where you have to do both.” Prof. Allan Belzberg ▶️ Watch the expert conversation and earn CME credit. This activity is for healthcare professionals globally, excluding the UK. This activity is funded by an independent medical education grant from Alexion and SpringWorks Therapeutics, Inc. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. #NF1 #PlexiformNeurofibromas #NF1PN #MedicalEducation #CME #Oncology #Neurosurgery #HCP

❓ Could targeting vitamin A processing offer a way to treat patients with Stargardt disease? Vitamin A is essential for vision, but in Stargardt disease ABCA4 dysfunction can disrupt vitamin A processing and lead to the accumulation of toxic byproducts. Join vitreoretinal surgeon Dr. Christine Kay as she explores the pathogenesis of Stargardt disease and emerging treatment approaches targeting retinoid biology. 🔎 Explore the role of vitamin A in the visual cycle 👁️ Examine how altered vitamin A processing contributes to disease pathogenesis 📊 Review clinical evidence and key safety considerations for investigational treatment approaches ▶️ Advance your knowledge and earn CME credit with this ACCME-accredited touchEXPERT FOCUS activity, designed for ophthalmologists and retina specialists. Watch the activity now! This activity is funded by an independent medical education grant from Alkeus Pharmaceuticals, Inc. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. #StargardtDisease #Retina #Ophthalmology #MedicalEducation #CME